Author:
Verbovoy A F,Barabanova N A
Abstract
The paper presents the results of studying the actual treatment of patients with type 2 diabetes (T2D) receiving oral glucose-reducing agents. The case reports of 291 patients with T2D were analyzed. Poor adherence to the international and Russian guidelines for the management of T2D, unsatisfactory control of cardiovascular risk factors, and untimely correction of glucose-reducing therapy were revealed.
Publisher
Endocrinology Research Centre
Subject
Endocrinology, Diabetes and Metabolism
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献